...
首页> 外文期刊>Surgical infections >Factors Associated with Post-Operative Conversion to Methicillin-Resistant Staphylococcus Aureus Positivity or Infection in Initially MRSA-Negative Patients
【24h】

Factors Associated with Post-Operative Conversion to Methicillin-Resistant Staphylococcus Aureus Positivity or Infection in Initially MRSA-Negative Patients

机译:最初MRSA阴性患者手术后转化为耐甲氧西林金黄色葡萄球菌阳性或感染的相关因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) is associated with morbid, invasive infections and has been implicated in nearly every type of nosocomial infection. Our aim was to identify the risk factors for patient conversion from MRSA negativity pre-operatively to MRSA positivity post-operatively. Methods: We retrospectively reviewed all patients at the Veterans Affairs-Boston Health Care System who underwent clean or clean-contaminated surgical procedures during the years 2008 and 2009 and had documented pre-operative nasal polymerase chain reaction (PCR) testing for MRSA. We abstracted post-operative MRSA microbiologic testing results, MRSA infections, surgical site infections (SSIs), surgical prophylaxis data, and SSI risk index, as calculated using the Veterans Affairs Surgical Quality Improvement Project (VASQIP) database variables. All patients who had a negative nasal MRSA PCR result in the 31-day pre-operative period and did not have any positive MRSA clinical swab or culture in the 1-year pre-operative period were defined as MRSA-negative. These patients were classified as converters to MRSA positivity if they had at least one documented positive nasal MRSA PCR swab, culture, nosocomial infection, or SSI within 31 days post-operatively. Results: Among 4,238 eligible patients, 3,890 (92%) qualified as MRSA-negative pre-operatively. A total of 1,432 (37%) of these patients were assessed in the VASQIP database, of whom 34 (2%) converted to MRSA positivity post-operatively. On multivariable logistic regression analysis of the VASQIP sample, age (odds ratio [OR] 1.049; 95% confidence interval [CI] 1.016, 1.083), SSI risk index (OR 2.863; 95% CI 1.251-6.554), and vancomycin prophylaxis alone or in combination (OR 3.223; 95% CI 1.174-8.845) were significantly associated with conversion to MRSA positivity. Conclusion: In pre-operatively MRSA-negative patients, age, SSI risk index, and vancomycin prophylaxis were significant factors for conversion to MRSA positivity post-operatively. Alternatives to vancomycin prophylaxis in non-colonized patients and optimization of patients' SSI risk factors should be considered before elective surgery.
机译:背景:医院获得的耐甲氧西林的金黄色葡萄球菌(MRSA)与病态的侵袭性感染有关,并且几乎与每种类型的医院感染有关。我们的目的是确定患者从术前MRSA阴性转变为术后MRSA阳性的危险因素。方法:我们回顾性研究了在2008年至2009年间接受过干净或干净污染的外科手术的退伍军人事务波士顿卫生系统的所有患者,并记录了MRSA的术前鼻聚合酶链反应(PCR)测试。我们提取了术后MRSA微生物学检测结果,MRSA感染,手术部位感染(SSI),手术预防数据和SSI风险指数,这些数据是使用退伍军人事务外科手术质量改善计划(VASQIP)数据库变量计算得出的。术前31天鼻MRSA PCR结果阴性且术前1年内无任何MRSA临床拭子或培养阳性的患者均被定义为MRSA阴性。如果这些患者在术后31天内至少有一份经记录的鼻MRSA PCR拭子,培养物,医院感染或SSI阳性,则被归类为MRSA阳性。结果:在4238名合格患者中,有3890名(92%)术前符合MRSA阴性标准。在VASQIP数据库中评估了1,432名患者(37%),其中34名(2%)术后转化为MRSA阳性。在对VASQIP样本进行多变量logistic回归分析时,年龄(赔率[OR] 1.049; 95%置信区间[CI] 1.016、1.083),SSI风险指数(OR 2.863; 95%CI 1.251-6.554)和万古霉素单独预防或联合使用(OR 3.223; 95%CI 1.174-8.845)与转化为MRSA阳性显着相关。结论:在术前MRSA阴性的患者中,年龄,SSI危险指数和万古霉素预防是术后转为MRSA阳性的重要因素。择期手术前,应考虑使用非万古霉素预防性替代药物和优化患者SSI危险因素。

著录项

  • 来源
    《Surgical infections》 |2011年第6期|p.435-442|共8页
  • 作者单位

    Departments of Surgery, Leadership, and Management Research at the Veterans Affairs Boston Healthcare System, Boston, Massachusetts,Boston University School of Medicine, Boston, Massachusetts;

    Departments of Medicine Leadership, and Management Research at the Veterans Affairs Boston Healthcare System, Boston, Massachusetts,Boston University School of Medicine, Boston, Massachusetts;

    Departments of Medicine Leadership, and Management Research at the Veterans Affairs Boston Healthcare System, Boston, Massachusetts,Harvard Medical School, Boston, Massachusetts;

    Departments of Center for Organization, Leadership, and Management Research at the Veterans Affairs Boston Healthcare System, Boston, Massachusetts;

    Departments of Surgery, Leadership, and Management Research at the Veterans Affairs Boston Healthcare System, Boston, Massachusetts,Boston University School of Medicine, Boston, Massachusetts,Harvard Medical School, Boston, Massachusetts,VA Boston HCS 1400 VFW Pkwy, Rm. 1B-130 West Roxbury, MA 02132;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号